FDA Adverse Event Injury Summary report: N

MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MDR report key: 6849934 · Received September 7, 2017

Report

Report Number
2025587-2017-01558
Event Type
Injury
Date Received
September 7, 2017
Date of Event
October 3, 2016
Report Date
August 15, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
LWR
PMA / PMN Number
P990064
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: LOYALKA, P. TRANSCATHETER AORTIC VALVE IMPLANTATION WITH A SAPIEN 3 COMMANDER 20 MM VALVES IN PATIENTS WITH DEGENERATED 19 MM BIOPROSTHETIC AORTIC VALVE. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. (2017); 89:1280¿1285. DOI 10.1002/CCD.26723. EARLIEST DATE OF E-PUBLISH/PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT CANNOT BE DETERMINED WHETHER THIS EVENT HAS BEEN PREVIOUSLY REPORTED. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW REGARDING THE IMPLANT OF TRANSCATHETER BIOPROSTHETIC VALVES INTO DEGENERATED SURGICAL VALVES. ALL DATA WERE COLLECTED FROM A SINGLE CENTER DATABASE BETWEEN 2015 AND 2016. THE STUDY POPULATION INCLUDED 5 PATIENTS, ONE OF WHICH HAD BEEN PREVIOUSLY IMPLANTED WITH A MEDTRONIC 19MM MOSAIC. NINE YEARS POST IMPLANT, STENOSIS AND SUBSEQUENT INCREASED GRADIENTS ALONG WITH TRACE PARAVALVULAR LEAK (PVL) WERE NOTED. SUBSEQUENTLY, A TRANSCATHETER BIOPROSTHETIC VALVE WAS IMPLANTED VALVE-IN-VALVE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
628546 MOSAIC AORTIC BIOPROSTHETIC HEART VALVE HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC HEART VALVES DIVISION 305_MOSAIC

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention